FSH Purification via Chromatography and Antioxidants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying follicle-stimulating hormone (FSH) are costly and involve immunoaffinity chromatography, which is expensive and can introduce undesired impurities, necessitating the development of a more efficient and cost-effective purification process.
Innovation Solution
A method involving dye-affinity chromatography, hydrophobic interaction chromatography, and reverse phase chromatography, potentially with additional steps like ion exchange and ultrafiltration/diafiltration, to achieve high purity FSH without relying on immunoaffinity chromatography, using antioxidants like L-methionine to prevent oxidation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If immunoaffinity chromatography is used to purify FSH, then high purity FSH is achieved, but the process becomes costly and introduces undesired impurities
Solution Approach 1:
The patent extracts and eliminates the immunoaffinity chromatography step from the purification process, replacing it with alternative chromatography methods (ion exchange, hydrophobic interaction, reverse phase) that achieve comparable purity without the high costs and impurity introduction associated with immunoaffinity approaches
Solution Approach 2:
The patent employs conventional chromatography resins and materials that are less expensive than immunoaffinity reagents, using multiple sequential purification steps with affordable materials to achieve the same high purity outcome without relying on costly specialized reagents
2Manufacturing precision
If immunoaffinity chromatography is used to purify FSH, then high purity FSH is achieved, but undesired impurities are introduced
Solution Approach 1:
The patent removes the immunoaffinity chromatography step that introduces undesired impurities, replacing it with a sequence of conventional chromatography methods that purify FSH without contaminating it with immunoglobulins or other impurities associated with immunoaffinity reagents
Solution Approach 2:
The patent changes the purification parameters by using different chromatography mechanisms (ion exchange, hydrophobic interaction, reverse phase) with varying selectivity and binding characteristics, achieving high purity through multiple orthogonal separation mechanisms rather than a single immunoaffinity step
3Manufacturing precision
If multiple purification steps are used to achieve high purity FSH, then purity is improved, but the process complexity increases
Solution Approach 1:
The patent segments the purification process into distinct functional stages (capture, intermediate purification, polishing) using different chromatography modalities, where each step targets specific impurity classes and collectively achieves high overall purity through systematic division of the purification task
4Ease of manufacture
If conventional chromatography methods are used instead of immunoaffinity, then cost is reduced, but achieving high purity becomes more difficult
Solution Approach 1:
The patent merges multiple conventional chromatography methods (ion exchange, hydrophobic interaction, reverse phase) into a sequential purification train, combining their complementary strengths to achieve high purity FSH without relying on expensive immunoaffinity chromatography
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high purity FSH with enhanced bioactivity and eliminates the need for costly immunoaffinity steps, reducing impurities and operational costs while maintaining high specific activity.
Implementation Method 1
dye-affinity chromatography
Implementation Method 2
hydrophobic interaction chromatography
Implementation Method 3
reverse phase chromatography
Implementation Method 4
using antioxidants like L-methionine to prevent oxidation
Data Source
AI summary
The invention relates to a method for purifying recombinant human FSH or an FSH variant starting from crude FSH, comprising the following steps: 1) dye-affinity chromatography; 2) hydrophobic interaction chromatography; and 3) reverse phase chromatography.